Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Conclusions:
The efficacy of roflumilast appears modest compared with other available therapies for COPD. Further studies are needed to investigate the risk–benefit ratio and long-term safety of roflumilast before its wider use.
Source: Therapeutic Advances in Respiratory Disease - Category: Respiratory Medicine Authors: Oba, Y., Lone, N. A. Tags: Original Research Source Type: research